Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2022 Nov 16;167(5):1810–1820.e2. doi: 10.1016/j.jtcvs.2022.10.054

Figure 1 and Graphical Abstract:

Figure 1 and Graphical Abstract:

Impact of Tricuspid Valve Treatment on Post-operative Right Heart Failure. Patients with moderate or severe TR undergoing LVAD implantation were randomized to undergo concurrent TVS versus No TVS. At 6-months, there was no significant difference in the incidence rate or severity of RHF between TVS and No TVS.